WELLGISTICS HEALTH INC (WGRX) Fundamental Analysis & Valuation

NASDAQ:WGRX • US9495031067

Current stock price

0.1078 USD
-0.01 (-6.26%)
At close:
0.1078 USD
0 (0%)
After Hours:

This WGRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. WGRX Profitability Analysis

1.1 Basic Checks

  • In the past year WGRX has reported negative net income.
  • In the past year WGRX has reported a negative cash flow from operations.
WGRX Yearly Net Income VS EBIT VS OCF VS FCFWGRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • With a Return On Assets value of -332.49%, WGRX is not doing good in the industry: 95.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -332.49%
ROE N/A
ROIC N/A
ROA(3y)-400.05%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WGRX Yearly ROA, ROE, ROICWGRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 -2K -4K -6K -8K

1.3 Margins

  • WGRX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WGRX Yearly Profit, Operating, Gross MarginsWGRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. WGRX Health Analysis

2.1 Basic Checks

  • WGRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for WGRX has been increased compared to 1 year ago.
  • WGRX has a worse debt/assets ratio than last year.
WGRX Yearly Shares OutstandingWGRX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 20M 40M 60M 80M 100M
WGRX Yearly Total Debt VS Total AssetsWGRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of -13.99, we must say that WGRX is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -13.99, WGRX is not doing good in the industry: 89.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.99
ROIC/WACCN/A
WACC12.16%
WGRX Yearly LT Debt VS Equity VS FCFWGRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M -5M 10M -10M

2.3 Liquidity

  • A Current Ratio of 0.09 indicates that WGRX may have some problems paying its short term obligations.
  • WGRX has a worse Current ratio (0.09) than 95.00% of its industry peers.
  • A Quick Ratio of 0.04 indicates that WGRX may have some problems paying its short term obligations.
  • WGRX has a worse Quick ratio (0.04) than 95.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.04
WGRX Yearly Current Assets VS Current LiabilitesWGRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. WGRX Growth Analysis

3.1 Past

  • WGRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -883.25%.
  • Looking at the last year, WGRX shows a very strong growth in Revenue. The Revenue has grown by 28.73%.
EPS 1Y (TTM)-883.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.83%
Revenue 1Y (TTM)28.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-86.54%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WGRX Yearly Revenue VS EstimatesWGRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

0

4. WGRX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WGRX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WGRX Price Earnings VS Forward Price EarningsWGRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WGRX Per share dataWGRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WGRX Dividend Analysis

5.1 Amount

  • WGRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WGRX Fundamentals: All Metrics, Ratios and Statistics

WELLGISTICS HEALTH INC

NASDAQ:WGRX (4/29/2026, 6:42:06 PM)

After market: 0.1078 0 (0%)

0.1078

-0.01 (-6.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength46.58
Industry Growth8.07
Earnings (Last)03-09
Earnings (Next)05-01
Inst Owners1.87%
Inst Owner Change1.75%
Ins Owners26.96%
Ins Owner Change0%
Market Cap13.72M
Revenue(TTM)23.34M
Net Income(TTM)-101.27M
AnalystsN/A
Price TargetN/A
Short Float %20.49%
Short Ratio1.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.18
BVpS-0.1
TBVpS-0.3
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -332.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-400.05%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.45%
Cap/Sales 3.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.04
Altman-Z -13.99
F-Score2
WACC12.16%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-883.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-86.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1221.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-632.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-786.12%
OCF growth 3YN/A
OCF growth 5YN/A

WELLGISTICS HEALTH INC / WGRX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of WELLGISTICS HEALTH INC (WGRX) stock?

ChartMill assigns a fundamental rating of 0 / 10 to WGRX.


What is the valuation status for WGRX stock?

ChartMill assigns a valuation rating of 0 / 10 to WELLGISTICS HEALTH INC (WGRX). This can be considered as Overvalued.


How profitable is WELLGISTICS HEALTH INC (WGRX) stock?

WELLGISTICS HEALTH INC (WGRX) has a profitability rating of 0 / 10.


Can you provide the financial health for WGRX stock?

The financial health rating of WELLGISTICS HEALTH INC (WGRX) is 0 / 10.